Home / Inspections / 1266180

FDA Inspection 1266180 — BioGenetics Corporation

BioGenetics Corporation — FEI 3001236618

The FDA completed an inspection of BioGenetics Corporation on March 14, 2025 in Mountainside, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mountainside, NJ (United States)

Facility

Other inspections at this facility

  • 1218002 (NAI Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1111175 (NAI Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058721 (NAI Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 985822 (NAI Fri Aug 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 855708 (NAI Thu Nov 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources